Zimmer Biomet announces 510(k) clearance for Zyston strut open titanium interbody spacer system

The Zyston strut open titanium interbody spacer system

The US Food and Drug Administration (FDA) has given 510(k) clearance for the Zyston strut open titanium interbody spacer system (Zimmer Biomet). This marks Zimmer Biomet’s first titanium spinal implant manufactured via a 3D printing process.

The Zyston strut open titanium system is a family of lumbar cages designed to enhance the strength, graft capacity and visualisation of the interbody spacer in spinal fusion cases. The cages will be available in a series of sizes to accommodate a range of patient anatomies and surgical approaches. The system also includes surgical instruments for insertion, manipulation and removal of the implants.

“The Zyston strut open titanium interbody spacer system is available in straight and curved profiles and is uniquely designed to provide surgeons with an option that optimises the balance of strength and graft capacity in spinal fusion cases,” says orthopaedic surgeon Frank Schwab, (New York, USA). “I have worked with a variety of Zimmer Biomet’s spine products and am looking forward to offering my fusion patients this latest innovation.”

“The Zyston strut open titanium spacer is manufactured using a 3D printing process, which allows us to create a unique cage architecture that maximises graft volume prior to implantation,” says Rebecca Whitney, General Manager of Zimmer Biomet’s Spine division. “The system marks our first 3D printed titanium spinal implant and adds to our comprehensive offering of lumbar spacers that are available in PEEK-Optima, Trabecular Metal Technology and allograft.”


Please enter your comment!
Please enter your name here